{"title":"Collaborative care for retinal artery occlusion by ophthalmologists and vascular neurologists: management of systemic complications.","authors":"Ayane Kamikawa, Kohei Kiyohara, Mariko Shirane, Sakurako Shimokawa, Takahiro Hisai, Yoshiyuki Kobayashi, Muneo Yamaguchi, Shoji Notomi, Keijiro Ishikawa, Takuya Kiyohara, Yoshinobu Wakisaka, Tetsuro Ago, Takanari Kitazono, Koh-Hei Sonoda, Kuniyuki Nakamura, Yusuke Murakami","doi":"10.1007/s10384-026-01345-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Retinal artery occlusion (RAO) is frequently associated with cerebrovascular and cardiovascular events, and guidelines highlight the need for secondary prevention. Since 2019, our hospital has implemented collaborative care between ophthalmologists and vascular neurologists for acute RAO, and here, we report the clinical outcomes before and after this approach.</p><p><strong>Study design: </strong>Retrospective observational study.</p><p><strong>Methods: </strong>Eighty-seven patients (mean age: 72.2 ± 13.4 years; 40 male) diagnosed with central retinal artery occlusion (CRAO), branch retinal artery occlusion (BRAO), or cilioretinal artery occlusion (CLRAO) at Kyushu University Hospital between March 2013 and May 2024 were retrospectively analyzed, and information on patient backgrounds, ocular and systemic examinations, and treatments was obtained.</p><p><strong>Results: </strong>The disease types were CRAO in 58, BRAO in 24, and CLRAO in 5 patients. Systemic complications before and after collaborative care included hypertension (67% before vs 79% after), diabetes (28% vs 17%), dyslipidemia (41% vs 44%), cerebrovascular diseases (21% vs 10%), carotid artery diseases (18% vs 40%, P = 0.03), and cardiac diseases (3% vs 27%, P = 0.002). After initiation of collaborative care, the causes of RAO were identified as large-artery atherosclerosis (LAA) in 29%, cardioembolism (CE) in 23%, undetermined in 38%, other determined in 8%, and insufficient evaluation in 2% of the patients. Anticoagulants were commonly prescribed for patients with CE, whilst antiplatelet agents were prescribed for those with LAA or embolic stroke of undetermined source (ESUS).</p><p><strong>Conclusion: </strong>Integrated collaborative care facilitates prompt detection of systemic vascular complications and initiation of secondary preventive treatments in patients with RAO.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"843-851"},"PeriodicalIF":2.7000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10384-026-01345-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Retinal artery occlusion (RAO) is frequently associated with cerebrovascular and cardiovascular events, and guidelines highlight the need for secondary prevention. Since 2019, our hospital has implemented collaborative care between ophthalmologists and vascular neurologists for acute RAO, and here, we report the clinical outcomes before and after this approach.
Study design: Retrospective observational study.
Methods: Eighty-seven patients (mean age: 72.2 ± 13.4 years; 40 male) diagnosed with central retinal artery occlusion (CRAO), branch retinal artery occlusion (BRAO), or cilioretinal artery occlusion (CLRAO) at Kyushu University Hospital between March 2013 and May 2024 were retrospectively analyzed, and information on patient backgrounds, ocular and systemic examinations, and treatments was obtained.
Results: The disease types were CRAO in 58, BRAO in 24, and CLRAO in 5 patients. Systemic complications before and after collaborative care included hypertension (67% before vs 79% after), diabetes (28% vs 17%), dyslipidemia (41% vs 44%), cerebrovascular diseases (21% vs 10%), carotid artery diseases (18% vs 40%, P = 0.03), and cardiac diseases (3% vs 27%, P = 0.002). After initiation of collaborative care, the causes of RAO were identified as large-artery atherosclerosis (LAA) in 29%, cardioembolism (CE) in 23%, undetermined in 38%, other determined in 8%, and insufficient evaluation in 2% of the patients. Anticoagulants were commonly prescribed for patients with CE, whilst antiplatelet agents were prescribed for those with LAA or embolic stroke of undetermined source (ESUS).
Conclusion: Integrated collaborative care facilitates prompt detection of systemic vascular complications and initiation of secondary preventive treatments in patients with RAO.
目的:视网膜动脉闭塞(RAO)经常与脑血管和心血管事件相关,指南强调二级预防的必要性。自2019年以来,我院对急性RAO实施了眼科和血管神经科医师的协同护理,在此报告该方法前后的临床结果。研究设计:回顾性观察性研究。方法:回顾性分析2013年3月至2024年5月在九州大学医院诊断为视网膜中央动脉闭塞(CRAO)、视网膜分支动脉闭塞(BRAO)、睫状体视网膜动脉闭塞(CLRAO)的87例患者(平均年龄:72.2±13.4岁,男性40例),获取患者背景、眼部及全身检查及治疗信息。结果:CRAO 58例,BRAO 24例,CLRAO 5例。协同护理前后的全身性并发症包括高血压(术前67% vs术后79%)、糖尿病(28% vs 17%)、血脂异常(41% vs 44%)、脑血管疾病(21% vs 10%)、颈动脉疾病(18% vs 40%, P = 0.03)和心脏病(3% vs 27%, P = 0.002)。在开始协同治疗后,RAO的病因被确定为大动脉粥样硬化(LAA)(29%)、心脏栓塞(CE)(23%)、未确定(38%)、确定(8%)、评估不充分(2%)。抗凝剂通常用于CE患者,而抗血小板药物用于LAA或来源不明的栓塞性卒中(ESUS)患者。结论:综合协作护理有助于RAO患者及时发现全身血管并发症并启动二级预防治疗。
期刊介绍:
The Japanese Journal of Ophthalmology (JJO) was inaugurated in 1957 as a quarterly journal published in English by the Ophthalmology Department of the University of Tokyo, with the aim of disseminating the achievements of Japanese ophthalmologists worldwide. JJO remains the only Japanese ophthalmology journal published in English. In 1997, the Japanese Ophthalmological Society assumed the responsibility for publishing the Japanese Journal of Ophthalmology as its official English-language publication.
Currently the journal is published bimonthly and accepts papers from authors worldwide. JJO has become an international interdisciplinary forum for the publication of basic science and clinical research papers.